D. E. Shaw & Co., Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $4.84 Million - $20 Million	17,271,215 Added 20282.33%	17,356,369 $5.73 Million
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $334,130 - $526,412	-315,217 Reduced 78.73%	85,154 $98,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $490,888 - $697,373	389,594 Added 3615.05%	400,371 $676,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $17,350 - $27,373	10,777 New	10,777 $19,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $18,720 - $34,164	-15,600 Reduced 59.08%	10,805 $14,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $43,040 - $92,945	26,405 New	26,405 $44,000
Q2 2022 Aug 15, 2022	SELL	$2.2 - $4.2 $4.84 Million - $9.24 Million	-2,200,370 Reduced 99.49%	11,390 $27,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $5.45 Million - $16.7 Million	1,925,476 Added 672.58%	2,211,760 $8.91 Million
Q4 2021 Feb 14, 2022	SELL	$8.31 - $14.92 $5.05 Million - $9.07 Million	-607,904 Reduced 67.98%	286,284 $2.38 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $8.18 Million - $11.9 Million	894,188 New	894,188 $10.4 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.